Sentences with phrase «regenerative medicine company developing»
Novo Biosciences based of Bar Harbor, Maine is a regenerative medicine company developing small molecule therapies that reactivate and stimulate innate healing abilities in humans and animals.
https://mdibl.org/
San Diego, California, October 6, 2014 — ViaCyte, Inc., a privately - held regenerative medicine company developing a stem cell - derived islet replacement therapy for the treatment of diabetes, called VC - 01 ™, will give two presentations at the annual Stem Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as follows:
Cynata Therapeutics Limited is an Australian clinical - stage stem cell and regenerative medicine company developing therapies based on its proprietary Cymerus ™ stem cell technology platform.
Not exact matches
ViaCyte, a private company that has emerged as a leader in the field of regenerative medicine, is currently focused on developing a novel cell therapy for the treatment of diabetes.
San Diego, California, October 29, 2013 — ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty fcompany focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty fCompany was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty foreign.
ViaCyte is a privately - held, clinical - stage regenerative medicine company focused on developing a novel cell therapy for the treatment of diabetes.
SAN DIEGO and SAN FRANCISCO, February 23, 2017 — ViaCyte, Inc., a privately - held regenerative medicine company, and Beyond Type 1, a not - for - profit advocacy and education group for those living with type 1 diabetes, today announced a grant from Beyond Type 1 to support ViaCyte's efforts to develop a functional cure for type 1 and other insulin - requiring diabetes.
ViaCyte is a privately held, clinical - stage regenerative medicine company focused on developing a novel cell therapy for the treatment of diabetes.
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self - renewal properties of the body through specific control of the Wnt signaling pathway.
Vet - Stem, a company focused on bringing regenerative medicine technology to veterinarians, has developed a therapy to treat arthritis in dogs using the pet's own fat tissue!